Skip to main content
. 2012 Mar;88(3):260–268. doi: 10.1111/j.1600-0609.2011.01726.x

Fig. 1.

Fig. 1

Percentage of chelation-naïve (n = 123) and prechelated patients with myelodysplastic syndromes (n = 44) who attended follow-up visits.